Literature DB >> 19752258

Taking the stress out of individualizing ADHD drug therapy.

Melanie McLeod1, Tessa Laubscher, Loren Regier, Brent Jensen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19752258      PMCID: PMC2743587     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  16 in total

Review 1.  Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults.

Authors:  Laurence L Greenhill; Steven Pliszka; Mina K Dulcan; William Bernet; Valerie Arnold; Joseph Beitchman; R Scott Benson; Oscar Bukstein; Joan Kinlan; Jon McClellan; David Rue; Jon A Shaw; Saundra Stock
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2002-02       Impact factor: 8.829

Review 2.  Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. American Academy of Pediatrics.

Authors: 
Journal:  Pediatrics       Date:  2000-05       Impact factor: 7.124

3.  The child with ADHD: using the AAP Clinical Practice Guideline. American Academy of Pediatrics.

Authors:  C T Herrerias; J M Perrin; M T Stein
Journal:  Am Fam Physician       Date:  2001-05-01       Impact factor: 3.292

Review 4.  Clinical practice. Attention deficit-hyperactivity disorder.

Authors:  Marsha D Rappley
Journal:  N Engl J Med       Date:  2005-01-13       Impact factor: 91.245

5.  The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder.

Authors:  Steven R Pliszka; M Lynn Crismon; Carroll W Hughes; C Keith Corners; Graham J Emslie; Peter S Jensen; James T McCRACKEN; James M Swanson; Molly Lopez
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2006-06       Impact factor: 8.829

6.  Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers.

Authors:  P S Jensen; S P Hinshaw; J M Swanson; L L Greenhill; C K Conners; L E Arnold; H B Abikoff; G Elliott; L Hechtman; B Hoza; J S March; J H Newcorn; J B Severe; B Vitiello; K Wells; T Wigal
Journal:  J Dev Behav Pediatr       Date:  2001-02       Impact factor: 2.225

Review 7.  Integrated pharmacologic treatment of attention-deficit hyperactivity disorder (ADHD).

Authors:  Robert O Horst; Robert L Hendren
Journal:  Essent Psychopharmacol       Date:  2005

8.  Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder.

Authors: 
Journal:  Pediatrics       Date:  2001-10       Impact factor: 7.124

Review 9.  Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder.

Authors:  Steven Pliszka
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2007-07       Impact factor: 8.829

10.  Sudden death and use of stimulant medications in youths.

Authors:  Madelyn S Gould; B Timothy Walsh; Jimmie Lou Munfakh; Marjorie Kleinman; Naihua Duan; Mark Olfson; Laurence Greenhill; Thomas Cooper
Journal:  Am J Psychiatry       Date:  2009-06-15       Impact factor: 18.112

View more
  1 in total

1.  Effectiveness and safety of dexamphetamine sulfate (Attentin®) in the routine treatment of children and adolescents with ADHD: results from a 12-month non-interventional study.

Authors:  Henrik Uebel-von Sandersleben; Oliver Dangel; Roland Fischer; Michaela Ruhmann; Michael Huss
Journal:  Scand J Child Adolesc Psychiatr Psychol       Date:  2021-04-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.